27 results on '"Stollenwerk, Björn"'
Search Results
2. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
3. Cost-effectiveness of romosozumab for the treatment of postmenopausal women at very high risk of fracture in Canada
4. Economic modeling of risk-adapted screen-and-treat strategies in women at high risk for breast or ovarian cancer
5. Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
6. Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation
7. A Decision-Analytic Model to Assess the Cost-Effectiveness of Etelcalcetide vs. Cinacalcet
8. Depression-related treatment and costs in Germany: Do they change with comorbidity? A claims data analysis
9. Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach
10. The excess health care costs of KardioPro, an integrated care program for coronary heart disease prevention
11. Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes
12. Cost-Effectiveness of an Individualized First-Line Treatment Strategy Offering Erlotinib Based on EGFR Mutation Testing in Advanced Lung Adenocarcinoma Patients in Germany
13. Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation
14. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12Cmutation: a randomised, open-label, phase 3 trial
15. Costs and effects of intra-operative fluorescence molecular imaging – A model-based, early assessment
16. Reporting health care decision models: a prospective reliability study of a multidimensional evaluation framework.
17. Exploring the potential value of improved care for secondary hyperparathyroidism with a novel calcimimetic therapy
18. Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation
19. Reporting health care decision models: a prospective reliability study of a multidimensional evaluation framework
20. Economic evaluation of genetic screening for Lynch syndrome in Germany
21. The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance
22. Effects of a 3-Year Nurse-Based Case Management in Aged Patients with Acute Myocardial Infarction on Rehospitalisation, Mortality, Risk Factors, Physical Functioning and Mental Health. A Secondary Analysis of the Randomized Controlled KORINNA Study
23. Cost-of-illness studies based on massive data: a prevalence-based, top-down regression approach
24. The Effectiveness of the Cardiovascular Disease Prevention Programme ‘KardioPro’ Initiated by a German Sickness Fund: A Time-to-Event Analysis of Routine Data
25. Cost Effectiveness of Rivaroxaban for Stroke Prevention in German Patients with Atrial Fibrillation
26. The cost-effectiveness of UGT1A1 genotyping before colorectal cancer treatment with irinotecan from the perspective of the German statutory health insurance.
27. Communicating the Parameter Uncertainty in the IQWiG Efficiency Frontier to Decision-Makers.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.